Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism
Open Access
- 1 December 2001
- journal article
- case report
- Published by BMJ in British Journal of Ophthalmology
- Vol. 85 (12) , 1429-1431
- https://doi.org/10.1136/bjo.85.12.1429
Abstract
AIMS To describe the phenotype in three family members affected by a novel mutation in the gene coding for the enzyme tissue inhibitor of metalloproteinase-3 (TIMP-3). METHODS Three members of the same family were seen with a history of nyctalopia and visual loss due to maculopathy. Clinical features were consistent with Sorsby's fundus dystrophy. Exon 5 of the gene coding for TIMP-3 was amplified by the polymerase chain reaction, single strand conformation polymorphism analysis undertaken and exon 5 amplicons were directly sequenced. RESULTS Onset of symptoms was in the third to fourth decade. Five of six eyes had geographic macular atrophy rather than neovascularisation as a cause for central visual loss. Peripheral retinal pigmentary disturbances were present. Scotopic ERGs were abnormal in all three. Mutation analysis showed a G→T transversion in all three resulting in a premature termination codon, E139X, deleting most of the carboxy terminal domain of TIMP-3. CONCLUSIONS The patients described had a form of Sorsby's fundus dystrophy which fell at the severe end of the spectrum of this disease. Postulated disease mechanisms include deposition of dimerised TIMP-3 protein.Keywords
This publication has 16 references indexed in Scilit:
- Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cellsAmerican Journal of Ophthalmology, 2000
- A Novel TIMP-3 Mutation Reveals a Common Molecular Phenotype in Sorsby's Fundus DystrophyJournal of Biological Chemistry, 2000
- TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.2000
- Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosaBritish Journal of Ophthalmology, 1998
- A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby’s fundus dystrophy with unusual clinical featuresHuman Genetics, 1998
- Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.Journal of Clinical Investigation, 1998
- A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical featuresHuman Molecular Genetics, 1995
- Night blindness in Sorsby's fundus dystrophy reversed by vitamin ANature Genetics, 1995
- Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP)Biochemical Journal, 1990
- A FUNDUS DYSTROPHY WITH UNUSUAL FEATURES (Late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalised choroidal atrophy with massive pigment proliferation)British Journal of Ophthalmology, 1949